ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
7
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Supplemental Information - Voluntary Suspension
|
|
stotes
|
12 |
2.5K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
12
|
2.5K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
46 |
15K |
15 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
46
|
15K
|
15
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
46 |
15K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
15K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
46 |
15K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
15K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
46 |
15K |
8 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
15K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
46 |
15K |
25 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
46
|
15K
|
25
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
7.0K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
35
|
7.0K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
7.0K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
35
|
7.0K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: ASA Milestone Achieved for $0.6m Grant Payment
|
|
stotes
|
4 |
1.5K |
21 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4
|
1.5K
|
21
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
2 |
11/03/24 |
11/03/24 |
Charts
|
2.7K
|
1.5M
|
2
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
7.0K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
35
|
7.0K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Board Changes
|
|
stotes
|
17 |
5.0K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
17
|
5.0K
|
8
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
7.0K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
35
|
7.0K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
7.0K |
8 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
35
|
7.0K
|
8
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
5 |
04/03/24 |
04/03/24 |
Charts
|
2.7K
|
1.5M
|
5
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Broward Health signs 2 year agreement for rollout HeraCARE
|
|
stotes
|
36 |
7.9K |
7 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
36
|
7.9K
|
7
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
3 |
04/03/24 |
04/03/24 |
Charts
|
2.7K
|
1.5M
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
15 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
15
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Becoming a substantial holder
|
|
stotes
|
1 |
693 |
17 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1
|
693
|
17
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
11 |
29/02/24 |
29/02/24 |
Charts
|
2.7K
|
1.5M
|
11
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
13 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
13
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Strategic A$15.28M Investment from Keysight Technologies
|
|
stotes
|
33 |
11K |
30 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
33
|
11K
|
30
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
16 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
16
|
|
ASX - By Stock
|
EMV |
Re:
Crossings, Special Crossings ETC
|
|
stotes
|
4 |
1.0K |
10 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.0K
|
10
|
|
ASX - By Stock
|
EMV |
Crossings, Special Crossings ETC
|
|
stotes
|
4 |
1.0K |
9 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.0K
|
9
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
7 |
21/02/24 |
21/02/24 |
Charts
|
2.7K
|
1.5M
|
7
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
stotes
|
677 |
167K |
5 |
26/01/24 |
26/01/24 |
Charts
|
677
|
167K
|
5
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
17 |
16/01/24 |
16/01/24 |
Charts
|
2.7K
|
1.5M
|
17
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic collaboration and commercial agreement with GPEx
|
|
stotes
|
9 |
1.9K |
3 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
9
|
1.9K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
8 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
8
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
17 |
08/01/24 |
08/01/24 |
Charts
|
2.7K
|
1.5M
|
17
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
23 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
23
|
|
ASX - By Stock
|
EMV |
Re:
EMV on ABC news - getting exciting now!
|
|
stotes
|
22 |
10K |
13 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
22
|
10K
|
13
|
|
ASX - By Stock
|
NIS |
Re:
NIS chart
|
|
stotes
|
641 |
141K |
8 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
641
|
141K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
|
|
stotes
|
5 |
2.6K |
21 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
5
|
2.6K
|
21
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
12 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
12
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
10 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
10
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
17 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
17
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Becoming a substantial holder
|
|
stotes
|
5 |
1.9K |
2 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
5
|
1.9K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
17 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
17
|
|
ASX - By Stock
|
BGT Biotech |
Re:
BioGene Media
|
|
stotes
|
102 |
33K |
4 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
102
|
33K
|
4
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.7K |
1.5M |
18 |
28/11/23 |
28/11/23 |
Charts
|
2.7K
|
1.5M
|
18
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
|
|
stotes
|
7 |
3.4K |
18 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
7
|
3.4K
|
18
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
6 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.4K |
1.1M |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
2.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
BGT |
Re:
Ann: BGT 2023AGM - Chairman's Address
|
|
stotes
|
11 |
2.3K |
5 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
11
|
2.3K
|
5
|
|
ASX - By Stock
|
BGT |
Re:
Ann: BGT 2023AGM - Chairman's Address
|
|
stotes
|
11 |
2.3K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
11
|
2.3K
|
2
|
|